Security key
47010C888
Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (JAGX)
CUSIP: 47010C888
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 6,991,905
- Total 13F shares
- 256,092
- Share change
- +191,279
- Total reported value
- $94,198
- Price per share
- $0.37
- Number of holders
- 10
- Value change
- +$53,197
- Number of buys
- 6
- Number of sells
- 4
Report period
Q1 2026
Institutions
10
Top holders
10
JAGX full security history
Previous quarter: Q4 2025
Jaguar Health, Inc. SEC filings
Jaguar Health, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 47010C888
Recent filing periods:
Top shareholders of JAGX - Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Uptown Capital, LLC |
13D/G
|
John Fife and Fredrick Waid |
9.9%
|
1,290,000
|
$322,500 | $0 | 29 Jan 2025 | |
| Iliad Research & Trading, L.P. |
13D/G
|
— |
9.8%
|
440,000
|
$748,000 | $0 | 11 Dec 2025 | |
| Joshua Mailman |
13D/G
|
— |
8.4%
|
587,320
|
$845,741 | $0 | 17 Dec 2025 | |
| INTRACOASTAL CAPITAL, LLC |
13D/G
|
Mitchell P. Kopin |
5%
|
65,002
|
$779,374 | $0 | 20 May 2025 | |
| CVI Investments, Inc. |
13D/G
|
— |
4.6%
|
164,204
|
$346,470 | +$36,300 | 30 Sep 2025 | |
| Lincoln Alternative Strategies LLC |
3/4/5
|
10%+ Owner |
8.6%
|
600,000
|
$1,284,000 | — | 28 Aug 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
24,048
|
$22,392 | — | 31 Dec 2025 | |
| DRW Securities, LLC |
13F
|
Company |
0.25%
|
17,823
|
$16,596 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.18%
|
12,451
|
$11,594 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.09%
|
6,395
|
$5,954 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.05%
|
3,609
|
$3,361 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
702
|
$1,000 | — | 31 Dec 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
220
|
$205 | — | 31 Dec 2025 | |
| Leonteq Securities AG |
13F
|
Company |
0%
|
188
|
$175 | — | 31 Dec 2025 | |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0%
|
45
|
$42 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
30
|
$28 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
4
|
$4 | — | 31 Dec 2025 | |
| Lisa A. Conte |
3/4/5
|
Chief Exec. Officer & President, Director |
—
mixed-class rows
|
76,312
mixed-class rows
|
$473,128,965 | — | 11 Dec 2025 | |
| Jonathan B. Siegel |
3/4/5
|
Director |
—
mixed-class rows
|
33,262
mixed-class rows
|
$473,112,619 | — | 11 Dec 2025 | |
| Jonathan S. Wolin |
3/4/5
|
Chief of Staff, Chief Compliance Officer & General Counsel |
—
mixed-class rows
|
42,140
mixed-class rows
|
$473,111,818 | — | 11 Dec 2025 | |
| John Micek |
3/4/5
|
Director |
—
mixed-class rows
|
33,269
mixed-class rows
|
$473,104,383 | — | 11 Dec 2025 | |
| Pravin R. Chaturvedi |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
31,063
mixed-class rows
|
$75,720,294 | — | 11 Dec 2025 | |
| Steven R. King |
3/4/5
|
Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary |
—
mixed-class rows
|
31,010
mixed-class rows
|
$87,466 | — | 11 Dec 2025 | |
| Carol R. Lizak |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
34,451
mixed-class rows
|
$20,248 | — | 11 Dec 2025 | |
| James J. Bochnowski |
3/4/5
|
Director |
—
mixed-class rows
|
68,168
mixed-class rows
|
$10,905 | — | 11 Dec 2025 | |
| Anula Jayasuriya |
3/4/5
|
Director |
—
mixed-class rows
|
11,786
mixed-class rows
|
$10,057 | — | 11 Dec 2025 | |
| Gregory J. Divis |
3/4/5
|
Director |
—
class O/S missing
|
12,133
|
$364 | — | 18 May 2022 |
Institutional Holders of Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (JAGX) as of Q1 2026
As of 31 Mar 2026,
Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (JAGX) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
256,092 shares.
The largest 10 holders included
UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP, TWO SIGMA SECURITIES, LLC, SBI Securities Co., Ltd., Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, Leonteq Securities AG, INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, and BlackRock, Inc..
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
10
Q1 2026 holders
10
Holder diff
0
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.